Literature DB >> 8533007

Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide (NO) signaling pathways.

B Brüne1, S Mohr, U K Messmer.   

Abstract

Nitric oxide signaling is achieved through both cGMP-dependent and cGMP-independent mechanisms. The latter are exemplified by protein thiol modification followed by subsequent NAD(+)-dependent automodification of the glycolytic enzyme GAPDH, or by mechanisms inducing accumulation of the tumor suppressor gene p53 and causing apoptotic cell death. Both cGMP-independent actions are initiated using NO-releasing compounds and an active LPS/cytokine-inducible NO synthase. NO-synthase inhibitors block the release of NO and hinder downstream signaling mechanisms; they are therefore valuable pharmacological tools linking a defined cellular response to various NO actions. Signal transducing mechanisms elicited by NO can be studied using GAPDH as a representative example of NO-induced protein modification and are grouped as follows: --S-Nitrosylation reactions initiated by NO+ --NAD(+)-dependent, post-translational covalent automodification of GAPDH --Oxidative modification (thiol oxidation) and inhibition of GAPDH by NO-related agents, probably ONOO- GAPDH and several other protein targets may serve as molecular sensors of elevated NO concentrations and may transmit this message through posttranslational modification and oxidation-induced conformational changes as cGMP-independent NO signaling pathways. Toxicity of NO seems to be linked to both apoptosis and necrosis, depending on the chemistry of NO it undergoes in a given biological milieu. Toxicity manifests as a relative excess of NOx, metal-NO interactions, and ONOO- formation in relation to cellular defense systems. Although accumulation of the tumor-suppressor gene product p53 in response to NO opens a regulatory mechanism known to be involved in apoptotic cell death, cGMP-independent signaling pathways remain to be elucidated. As NO-dependent modification of GAPDH would imply down-regulation of glycolysis and concomitant energy production followed by cell death, our data so far do not support this assumption. In recent years, NO has proved to be a beneficial messenger with a potentially toxic activity. It will be challenging to investigate NO biochemistry in closer detail and to elucidate how NO targets biological systems, especially in relation to its pathophysiological role.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8533007     DOI: 10.1007/bfb0048263

Source DB:  PubMed          Journal:  Rev Physiol Biochem Pharmacol        ISSN: 0303-4240            Impact factor:   5.545


  21 in total

1.  Nitric oxide induces heat-shock protein 70 expression in vascular smooth muscle cells via activation of heat shock factor 1.

Authors:  Q Xu; Y Hu; R Kleindienst; G Wick
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways.

Authors:  U K Messmer; B Brüne
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

3.  Modulation of potassium channel function by methionine oxidation and reduction.

Authors:  M A Ciorba; S H Heinemann; H Weissbach; N Brot; T Hoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

4.  Increased adipocyte S-nitrosylation targets anti-lipolytic action of insulin: relevance to adipose tissue dysfunction in obesity.

Authors:  Hilla Ovadia; Yulia Haim; Ori Nov; Orna Almog; Julia Kovsan; Nava Bashan; Moran Benhar; Assaf Rudich
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

5.  Molecular mechanism of the inactivation of tryptophan hydroxylase by nitric oxide: attack on critical sulfhydryls that spare the enzyme iron center.

Authors:  D M Kuhn; R Arthur
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

6.  A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response.

Authors:  Parimala Nacharaju; Chaim Tuckman-Vernon; Keith E Maier; Jason Chouake; Adam Friedman; Pedro Cabrales; Joel M Friedman
Journal:  Nitric Oxide       Date:  2012-06-15       Impact factor: 4.427

7.  NO-induced relaxation of labouring and non-labouring human myometrium is not mediated by cyclic GMP.

Authors:  I L Buxton; R A Kaiser; N A Malmquist; S Tichenor
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

Review 8.  Cross-talk between nitric oxide and transforming growth factor-beta1 in malaria.

Authors:  Yoram Vodovotz; Ruben Zamora; Matthew J Lieber; Shirley Luckhart
Journal:  Curr Mol Med       Date:  2004-11       Impact factor: 2.222

9.  S-nitrosylation of caspase-3 is the mechanism by which adhesion fibroblasts manifest lower apoptosis.

Authors:  Zhong L Jiang; Nicole M Fletcher; Michael P Diamond; Husam M Abu-Soud; Ghassan M Saed
Journal:  Wound Repair Regen       Date:  2009 Mar-Apr       Impact factor: 3.617

Review 10.  Main roads to melanoma.

Authors:  Giuseppe Palmieri; Mariaelena Capone; Maria Libera Ascierto; Giusy Gentilcore; David F Stroncek; Milena Casula; Maria Cristina Sini; Marco Palla; Nicola Mozzillo; Paolo A Ascierto
Journal:  J Transl Med       Date:  2009-10-14       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.